Ocular Oncology and Pathology

Scope & Guideline

Exploring Ocular Malignancies with Precision

Introduction

Explore the comprehensive scope of Ocular Oncology and Pathology through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Ocular Oncology and Pathology in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2296-4681
PublisherKARGER
Support Open AccessNo
CountrySwitzerland
TypeJournal
Convergefrom 2015 to 2024
AbbreviationOCUL ONCOL PATHOL / Ocul. Oncol. Pathol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND

Aims and Scopes

The journal 'Ocular Oncology and Pathology' focuses on advancing knowledge in the field of ocular tumors and associated pathologies. It emphasizes a multidisciplinary approach that integrates clinical, pathological, and imaging methodologies to improve diagnosis, treatment, and understanding of ocular malignancies.
  1. Ocular Tumor Diagnosis and Management:
    The journal covers a wide range of ocular tumors, including uveal melanoma, retinoblastoma, and conjunctival melanoma, focusing on innovative diagnostic techniques and treatment modalities.
  2. Pathological Insights into Ocular Conditions:
    It provides insights into the histopathological features of various ocular tumors, enhancing the understanding of their biological behavior and potential therapeutic targets.
  3. Multimodal Imaging Techniques:
    Research on advanced imaging modalities such as optical coherence tomography and magnetic resonance imaging is emphasized, aiding in the accurate diagnosis and monitoring of ocular tumors.
  4. Therapeutic Innovations:
    The journal highlights new treatment approaches, including brachytherapy, stereotactic radiosurgery, and chemotherapy, aiming to improve patient outcomes and minimize side effects.
  5. Epidemiological and Clinical Studies:
    It publishes studies on the epidemiology, clinical outcomes, and quality of life related to ocular malignancies, contributing to a comprehensive understanding of these diseases.
Recent publications in 'Ocular Oncology and Pathology' reveal several emerging themes that reflect the evolving landscape of ocular oncology research. These trends indicate a shift towards more personalized and precise approaches in the management of ocular tumors.
  1. Targeted Therapies and Personalized Medicine:
    There is an increasing focus on targeted therapies and personalized medicine, particularly in the context of uveal melanoma and retinoblastoma, as researchers seek to tailor treatments based on individual tumor characteristics.
  2. Integration of Genomic and Molecular Data:
    The incorporation of genomic and molecular studies into ocular oncology is on the rise, highlighting the importance of genetic profiling in predicting outcomes and guiding treatment strategies.
  3. Longitudinal Studies on Treatment Outcomes:
    Emerging themes include the need for longitudinal studies that assess long-term outcomes of various treatment modalities, reflecting a growing interest in survivorship and quality of life post-treatment.
  4. Multidisciplinary Approaches to Ocular Tumors:
    There is a notable trend towards multidisciplinary approaches, combining insights from oncology, pathology, radiology, and surgery to improve comprehensive care for patients with ocular tumors.
  5. Exploration of Immunotherapy:
    Research on the role of immunotherapy in the treatment of ocular malignancies is gaining prominence, as there is an increasing interest in harnessing the immune system to combat these cancers.

Declining or Waning

While the journal continues to thrive in several key areas, certain themes appear to be declining in prominence over time. This shift may reflect advancements in treatment and changes in research focus within the field.
  1. Traditional Chemotherapy for Ocular Tumors:
    There is a noticeable decrease in research focusing solely on traditional chemotherapy approaches for ocular tumors, as newer targeted therapies and immunotherapies gain traction in clinical practice.
  2. Non-Invasive Diagnostic Techniques:
    Although still relevant, the emphasis on less invasive diagnostic techniques has diminished, possibly due to the increasing sophistication and accuracy of imaging technologies.
  3. Histopathological Correlation without Clinical Context:
    Research that exclusively discusses histopathological findings without correlating them to clinical outcomes is becoming less common, as there is a growing demand for studies that integrate clinical and pathological data.

Similar Journals

Eye & Contact Lens-Science and Clinical Practice

Empowering professionals with essential eye care knowledge.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1542-2321Frequency: 6 issues/year

Eye & Contact Lens-Science and Clinical Practice, published by Lippincott Williams & Wilkins, stands as a premier journal in the fields of ophthalmology and contact lens research. With an ISSN of 1542-2321 and an E-ISSN of 1542-233X, this journal serves as a vital resource for researchers, clinicians, and students dedicated to the study and application of eye care practices. Maintaining a distinguished impact factor within the Q2 category of Medicine and Ophthalmology as of 2023, it ranks impressively at #33 among 137 journals, placing it in the top 76th percentile according to Scopus metrics. Since its inception in 1986, Eye & Contact Lens has consistently delivered cutting-edge research and clinical insights, facilitating advancements in therapeutic techniques for contact lens wear and ocular health. Though not an Open Access journal, it remains accessible through institutional subscriptions, ensuring that essential findings are shared among professionals in the field. The objective of the journal is to present high-quality, peer-reviewed articles that advance the science and practice of eye care, making it an indispensable tool for those seeking to enhance their knowledge and contribute to this dynamic discipline.

OPHTHALMOLOGY

Advancing ocular health through groundbreaking research.
Publisher: ELSEVIER SCIENCE INCISSN: 0161-6420Frequency: 12 issues/year

OPHTHALMOLOGY is a leading journal in the field of ocular health, widely recognized for its contributions to advancing the understanding and treatment of ophthalmic conditions. Published by ELSEVIER SCIENCE INC in the United States, it has earned a prestigious place within the academic community, boasting a remarkable Q1 ranking in the ophthalmology category for 2023, along with an impressive Scopus rank of #2 out of 137, placing it in the 98th percentile. With a strong publication history dating back to 1958, OPHTHALMOLOGY encompasses high-quality research articles, reviews, and clinical studies that address critical issues in the field. Researchers, professionals, and students alike can access its comprehensive research through traditional subscription options, fostering an ongoing dialogue among experts. Whether you are seeking the latest treatments, understanding complex ocular diseases, or looking to advance your knowledge, OPHTHALMOLOGY remains an essential resource for cutting-edge research and insights.

JAPANESE JOURNAL OF OPHTHALMOLOGY

Empowering Eye Health Through Innovative Research
Publisher: SPRINGER JAPAN KKISSN: 0021-5155Frequency: 6 issues/year

Japanese Journal of Ophthalmology, published by Springer Japan KK, is a premier peer-reviewed journal dedicated to advancing the field of ophthalmology. With an impressive impact reflected in its Q1 categories—ranking among the top journals in both Medicine (miscellaneous) and Ophthalmology, as per the 2023 metrics—it serves as an essential platform for researchers and professionals to disseminate their findings. Covering a broad spectrum of topics from clinical studies to innovative technologies in eye care, this journal not only supports the ongoing education of its readership but also fosters significant developments within the field. The journal, which has been in circulation since 1973 and is set to continue through 2024, offers access to vital research, thereby enabling practitioners and scholars to keep abreast of the latest advancements. Its distinguished Scopus ranking of #30 out of 137 in Medicine - Ophthalmology, placing it in the 78th percentile, further underscores its influence and importance in contributing to the global understanding of eye health.

EUROPEAN JOURNAL OF OPHTHALMOLOGY

Empowering Clinicians with Groundbreaking Findings
Publisher: SAGE PUBLICATIONS LTDISSN: 1120-6721Frequency: 6 issues/year

The EUROPEAN JOURNAL OF OPHTHALMOLOGY, published by SAGE PUBLICATIONS LTD, is a leading international journal in the field of ophthalmology, dedicated to advancing the understanding and treatment of ocular diseases and disorders. With an ISSN of 1120-6721 and an E-ISSN of 1724-6016, the journal aims to provide a platform for innovative research, critical reviews, and comprehensive studies that span the diverse aspects of the discipline. As part of its commitment to disseminating high-quality research, the journal is indexed in Scopus, achieving an impressive rank of #47 out of 137 in the Medicine - Ophthalmology category, indicating its strong impact within the academic community. With a current impact factor that places it in the Q2 quartile for both Medicine (miscellaneous) and Ophthalmology as of 2023, it offers researchers and practitioners access to important findings and developments in eye health. The journal's converged years from 1991 to 2024 exemplify its longstanding commitment to the field, making it an essential resource for anyone looking to stay at the forefront of ophthalmological research.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Pioneering Research for Better Vision
Publisher: SPRINGERISSN: 0721-832XFrequency: 12 issues/year

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, published by Springer, has established itself as a premier journal in the field of ophthalmology since its inception in 1870. With an ISSN of 0721-832X and an E-ISSN of 1435-702X, this esteemed journal enjoys a notable impact in the research community, ranking Q1 in Ophthalmology and Q1 in Sensory Systems, as per the latest 2023 journal category quartiles. GRAEFES Archive is dedicated to advancing our understanding of ocular health through both clinical and experimental studies, making it an essential resource for researchers, practitioners, and students alike. Its comprehensive scope covers various aspects of ophthalmic science, reflecting its long-standing commitment to quality and excellence. Although it currently operates on a subscription basis, the journal's significant Scopus rankings—24th out of 137 in Ophthalmology—underscore its relevance and influence within the scientific community. Situated in Germany, with its address in the United States, this international journal continues to shape the discourse on vision science and therapeutic innovation.

Case Reports in Ophthalmology

Fostering collaboration through peer-reviewed excellence.
Publisher: KARGERISSN: 1663-2699Frequency: 3 issues/year

Case Reports in Ophthalmology is an esteemed peer-reviewed journal published by KARGER, dedicated to advancing the field of ophthalmology through the dissemination of high-quality case reports. Since its establishment in 2010, the journal has maintained its Open Access model, ensuring that valuable research is accessible to a global audience, thus fostering collaboration and innovation in eye care. Hailing from Switzerland, the journal covers a broad range of topics within ophthalmology, providing a platform for clinicians and researchers to share unique clinical insights and pivotal findings. With a current impact factor that positions it within the Q3 category of ophthalmology in the 2023 rankings, Case Reports in Ophthalmology is a vital resource for professionals seeking to stay abreast of emerging trends and case studies in the field. Researchers and students alike will benefit from its rigorous peer-review process and its commitment to supporting quality research initiatives, making it an essential addition to any ophthalmology library.

Journal of Current Ophthalmology

Fostering Excellence: Your Source for Cutting-Edge Ophthalmology
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2452-2325Frequency: 4 issues/year

Journal of Current Ophthalmology is a premier scholarly platform dedicated to advancing the field of ophthalmology, published by Wolters Kluwer Medknow Publications. Established as an Open Access journal since 2015, it aims to provide unrestricted access to high-quality research that fosters knowledge sharing and collaboration among researchers, practitioners, and students in the field. The journal covers a broad spectrum of topics within ophthalmology, from clinical practices to groundbreaking research, contributing significantly to the medical community's understanding of eye health and diseases. With an impact factor reflecting its significance, it ranks in the Q2 category of ophthalmology and stands at #66 out of 137 in Scopus rankings, placing it in the 52nd percentile of its field as of 2023. The Journal of Current Ophthalmology is committed to publishing cutting-edge findings and innovative solutions, establishing itself as an essential resource for all professionals engaged in ocular research and care.

OCULAR IMMUNOLOGY AND INFLAMMATION

Empowering clinicians with essential ocular insights.
Publisher: TAYLOR & FRANCIS INCISSN: 0927-3948Frequency: 6 issues/year

Ocular Immunology and Inflammation is a distinguished academic journal dedicated to advancing the field of ocular immunology and ophthalmic inflammation. Published by Taylor & Francis Inc, this journal plays a crucial role in disseminating high-quality research findings, reviews, and clinical studies that address the complexities of immune responses in the eye and their implications in various ocular diseases. With an impressive impact factor and consistently ranking in the Q2 category in both Immunology and Allergy and Ophthalmology, it stands out as a vital resource for researchers, clinicians, and students alike. The journal's broad scope encompasses both experimental and clinical studies, ensuring a comprehensive exploration of the mechanisms and treatments of ocular inflammatory conditions. With its publication history dating from 1993 to 2024, this journal continues to be an essential reference for those seeking cutting-edge research and insights into ocular health. Researchers and professionals are encouraged to engage with the latest articles to inform their practice and advance their knowledge in this critical area of medicine.

Eye and Vision

Advancing the frontiers of ophthalmology and visual sciences.
Publisher: BMCISSN: 2326-0246Frequency: 1 issue/year

Eye and Vision, published by BMC, is a leading open-access journal dedicated to the dynamic field of ophthalmology and visual sciences. With its ISSN 2326-0246 and E-ISSN 2326-0254, the journal has established itself as a premier platform for innovative research and clinical studies, achieving impressive rankings in 2023 as Q1 in both Health Professions (Miscellaneous) and Ophthalmology categories. The journal's commitment to accessible knowledge since its transition to open access in 2015 enhances its global reach, allowing researchers, clinicians, and students to share and access top-tier studies and advancements in the field. Located in the United Kingdom and delivering influential insights from 2014 through to 2024, Eye and Vision holds significant relevance, with a Scopus ranking placing it in the 99th percentile for Health Professions and the 93rd percentile for Ophthalmology, making it an essential resource for those looking to stay at the forefront of eye research and vision science.

Nepalese Journal of Ophthalmology

Illuminating the Path to Better Eye Health
Publisher: NEPAL OPHTHALMIC SOCISSN: 2072-6805Frequency: 2 issues/year

Nepalese Journal of Ophthalmology, established by the NEPAL OPHTHALMIC SOC, is a premier Open Access journal dedicated to advancing the field of ophthalmology. With its ISSN 2072-6805 and E-ISSN 2091-0320, the journal provides an important platform for sharing innovative research and clinical findings in eye health. Since its inception in 2009, the journal has aimed to disseminate high-quality research that addresses contemporary challenges in ophthalmic practices, thus supporting improved patient care and outcomes within Nepal and beyond. The journal has achieved notable recognition, evidenced by its Scopus rank of #267 out of 915 in the field of General Medicine, placing it within the 70th percentile. Researchers, professionals, and students will find valuable information in its comprehensive articles, which cater to a multidisciplinary audience interested in the latest developments in ophthalmology. Emphasizing accessibility, the journal ensures that all published content is freely available, fostering collaboration and knowledge sharing in the global medical community.